SCHEMBL28061786

SCHEMBL28061786

CCCCCCCC/C=C\CCCCCCCC(=O)Oc1ccc2ccc(=O)oc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NDUFS8 O00217 3/20 0.58
COXFA4 O00483 3/20 0.58
NDUFAB1 O14561 3/20 0.58
NDUFA1 O15239 3/20 0.58
NDUFS4 O43181 3/20 0.58
NDUFB5 O43674 3/20 0.58
NDUFB3 O43676 3/20 0.58
NDUFC1 O43677 3/20 0.58
NDUFA2 O43678 3/20 0.58
NDUFS5 O43920 3/20 0.58
NDUFS7 O75251 3/20 0.58
NDUFS2 O75306 3/20 0.58
NDUFS6 O75380 3/20 0.58
NDUFB1 O75438 3/20 0.58
NDUFS3 O75489 3/20 0.58
NDUFB6 O95139 3/20 0.58
NDUFA3 O95167 3/20 0.58
NDUFB4 O95168 3/20 0.58
NDUFB8 O95169 3/20 0.58
NDUFB2 O95178 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12081709 0.94 NDUFS8 (0.57) NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4
SCHEMBL28529405 0.94 NDUFS8 (0.57) NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4
SCHEMBL712741 0.94 NDUFS8 (0.57) NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4
SCHEMBL4293165 0.93 CA12 (0.63) NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4
SCHEMBL1095981 0.93 CA12 (0.63) NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4
SCHEMBL19831442 0.93 CA12 (0.63) NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4
SCHEMBL21043916 0.92 CA12 (0.64) NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4
SCHEMBL3469406 0.89 NDUFS8 (0.53) NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4
SCHEMBL3470086 0.89 NDUFS8 (0.53) NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4
SCHEMBL3469861 0.88 CA12 (0.66) CA12CA9CA1CA6CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105457018-A Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients SYNAGEVA BIOPHARMA CORP 2016-04-06 CN disclosed